TranS1 Inc. Announces Participation in Two Investor Conferences in June 2012
WILMINGTON, N.C., May 30, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today it will participate in two investor conferences in June.
Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, are scheduled to present at the Sidoti & Company, LLC's Micro-Cap Conference in New York City on Thursday, June 14, 2012 at 8 a.m. ET and at the Wells Fargo Health Care Conference on Wednesday, June 20, 2012 at 3 p.m. ET in Boston, MA.
Mr. Reali and Mr. Slattery will discuss the Company and its progress toward gaining market share with its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region and will also conduct one-on-one meetings with institutional investors. Investors that wish to request a meeting with TranS1 should contact Sidoti and Company or Wells Fargo Securities.
About TranS1 Inc.
TranS1 is a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF® family of products for single and two level lumbar fusion, the VEOTM lateral access and interbody fusion system, and the VectreTM and AvatarTM posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.
CONTACT: Investors: TranS1 Inc. Joseph P. Slattery, 910-332-1700 Executive Vice-President and Chief Financial Officer Westwicke Partners Mark Klausner, 443-213-0501 firstname.lastname@example.org